Taxol given weekly in advanced previously treated ovarian carcinomas - a pilot study
- 1 July 1997
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 7 (4) , 262-266
- https://doi.org/10.1046/j.1525-1438.1997.00449.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceBritish Journal of Cancer, 1995
- Docetaxel (Taxotere): Single agent activity, development of combination treatment and reducing side-effectsCancer Treatment Reviews, 1995
- Paclitaxel-induced neuropathyAnnals of Oncology, 1995
- Peripheral neurotoxicity of taxol in patients previously treated with cisplatinCancer, 1995
- Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancerAnnals of Oncology, 1994
- Paclitaxel (Taxol) treatment for refractory ovarian cancer: Phase II clinical trialAmerican Journal of Obstetrics and Gynecology, 1994
- Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian CancerJNCI Journal of the National Cancer Institute, 1994
- Onycholysis in Doxorubicin-Treated PatientsArchives of Dermatology, 1990